Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
May 5, 2017
Document Date
May 5, 2017
Form Description
Notice of Exempt Offering of Securities
Filing Group
Other
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/